Literature DB >> 6863295

Accelerated transbilayer movement of phosphatidylcholine in sickled erythrocytes. A reversible process.

P F Franck, D T Chiu, J A Op den Kamp, B Lubin, L L van Deenen, B Roelofsen.   

Abstract

The transbilayer mobility of phosphatidylcholine (PC) molecules in the membrane of homozygous reversible sickle cells (RSCs) was studied using a PC-specific exchange protein from beef liver. In deoxygenated RSCs, all of the PC present in the membrane of the intact cell is rapidly available for exchange, mediated by this protein. Since a substantial amount of the PC is present in the inner membrane leaflet of these cells, this observation implies that the PC molecules in their membranes do experience rapid transbilayer movements. To determine the actual rate of transbilayer movement of the PC, radioactive PC was introduced into the outer monolayer of oxygenated RSCs using the PC-specific exchange protein. Subsequently, the cells were incubated at 37 degrees C under oxy- and deoxygenating conditions to enable the PC to equilibrate within the bilayer. At various time intervals, samples were taken and treated with phospholipase A2, which selectively degrades the PC in the outer monolayer. Analysis of the specific radioactivities of the lyso-PC thus produced, as well as of the residual PC, enabled us to follow the fate of the radioactive PC previously introduced into the outer membrane layer. The half-time value for transbilayer equilibration of the PC in deoxygenated RSCs was determined to be 3.5 h, which is about four times lower than that for oxygenated RSCs. This increased transbilayer mobility of PC, observed in deoxygenated RSCs, is immediately restored to the normal low rate upon reoxygenation of the cells, indicating a complete reversibility of this phenomenon.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6863295

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

Review 1.  Transmembrane movements of lipids.

Authors:  A Zachowski; P F Devaux
Journal:  Experientia       Date:  1990-06-15

2.  Human erythrocyte protein 4.1 is a phosphatidylserine binding protein.

Authors:  A C Rybicki; R Heath; B Lubin; R S Schwartz
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

3.  Abnormalities in the erythrocyte membrane in acute lymphoid leukaemia.

Authors:  M Kundu; J Basu; P Chakrabarti; M M Rakshit
Journal:  Biochem J       Date:  1989-03-15       Impact factor: 3.857

4.  In vivo externalization of phosphatidylserine and phosphatidylethanolamine in the membrane bilayer and hypercoagulability by the lipid peroxidation of erythrocytes in rats.

Authors:  S K Jain
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

5.  Rhnull human erythrocytes have an abnormal membrane phospholipid organization.

Authors:  F Kuypers; M van Linde-Sibenius-Trip; B Roelofsen; M J Tanner; D J Anstee; J A Op den Kamp
Journal:  Biochem J       Date:  1984-08-01       Impact factor: 3.857

6.  An intracellular simian malarial parasite (Plasmodium knowlesi) induces stage-dependent alterations in membrane phospholipid organization of its host erythrocyte.

Authors:  P Joshi; G P Dutta; C M Gupta
Journal:  Biochem J       Date:  1987-08-15       Impact factor: 3.857

7.  Lipid organization in erythrocyte membrane microvesicles.

Authors:  S Scott; S A Pendlebury; C Green
Journal:  Biochem J       Date:  1984-11-15       Impact factor: 3.857

8.  Red cell membrane remodeling in sickle cell anemia. Sequestration of membrane lipids and proteins in Heinz bodies.

Authors:  S C Liu; S J Yi; J R Mehta; P E Nichols; S K Ballas; P W Yacono; D E Golan; J Palek
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

9.  Abnormality of phospholipid transverse diffusion in sickle erythrocytes.

Authors:  A Zachowski; C T Craescu; F Galacteros; P F Devaux
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

10.  Sickling of sickle erythrocytes does not alter phospholipid asymmetry.

Authors:  P J Raval; D Allan
Journal:  Biochem J       Date:  1984-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.